Companies Ready to Supply Pharmacies in Canada with Legal Cannabis | CashCropToday
0 Shares 210 Views

Companies Ready to Supply Pharmacies in Canada with Legal Cannabis

March 23, 2018
210 Views

Wholly owned subsidiary of Privateer Holdings, Tilray, has signed an LOI to supply medical cannabis to Pharmasave, a pharmacy chain in Canada of more than 650 independently owned pharmacies. A number of different companies are attempting to jostle for position ahead of the planned legalization in Canada this year.

Other pharmacies such as Shoppers Drug Mart have signed similar deals with public companies like Aphria (TSX: APH), MedReleaf (TSX: LEAF), and Aurora Cannabis (TSX: ACB). Pharmacies look to play a huge role in the distribution of medical cannabis once legalization in Canada.

The news of this signed LOI comes amidst an important vote in the Canadian Senate, where the marijuana legalization bill passed 44 to 29. The bill now will move on to the Senate Social Affairs, Science and Technology committee for the final vote which is expected to happen on or before June 7, 2018.

You may be interested

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon
Market Watch
262 views
Market Watch
262 views

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon

Editor - November 27, 2018

Vancouver, BC -- (November 27, 2018) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) and its joint venture…

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition
Global
187 views
Global
187 views

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition

Editor - November 26, 2018

Wayland Group (CSE:WAYL) (OTCQB:MRRCF) has announced this morning that their company has entered into an agreement to acquire 51% of UK company Theros Pharma Ltd. The Wayland Group…

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials
Manufacturing
186 views
Manufacturing
186 views

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials

Editor - November 26, 2018

GW Pharmaceuticals (Nasdaq: GWPH) has announced this morning that their company has completed a double-blind, placebo-controlled Phase 3 clinical trial for its Cannabidiol (CBD) derived product EPIDIOLEX®.…

Leave a Comment

Your email address will not be published.

Most from this category

%d bloggers like this: